SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Libbyt who wrote (7901)6/11/1999 8:29:00 PM
From: Manly  Respond to of 9523
 
Libbyt,

This market is one of overreactions! If an investor is playing PFE like an internet stock, then indeed they will be disappointed and I suggest they move onward to another stock. We own a bunch of internet stocks in addition to drug stocks, etc. Drug stocks are our long term holds - we forget we own them, something like owning a 401K. Since, we're only 36 yrs. old - not too concerned about if PFE will be above it's current price in 10 years!

I'm hoping PFE hits the $80's pre split because, we'll be buying more! All this hype about it's a dead dog are completely unfounded. These are short term players in this stock who are looking to make a quick buck in a few weeks on PFE versus many of us in drug stocks who hold them longer term.

Based on our investment objective and our personal experience working in drug companies, we have no fear about buying at these levels with the news on Trovan. Trovan was not a blockbuster drug making $1 billion per year! What were the sales for the 1st quarter - $50 million? Liver problems are not a new problem for the quinilone class, I predict that Trovan will be pulled from the market like Omniflox was a few years ago and life goes on at PFE!

Let's see $90/3 = $30 per share in a few weeks. Can you imagine if PFE dips to $75 pre split? We'll be buying up another 1000-2000 shares at that price.

Have a great weekend.
Glenn